Quality Chemical Industries Ltd
Pharmaceuticals sector
Quality Chemical adds influenza drug to malaria, HIV portfolio
Quality Chemical Industries has signed a Medicines Patent Pool sublicence to manufacture generic baloxavir marboxil, Roche's flu drug, for 129 low- and middle-income countries
Quality Chemical Industries Limited: Post annual general meeting notice
At the Annual General Meeting (AGM) of the company held electronically on Thursday, 17 July 2025, the following resolutions were passed
Quality Chemical Industries Ltd
Quality Chemical shareholders approve $51m credit facilities
Quality Chemical Industries Limited shareholders voted in favour of the pharmaceutical company's $51m credit facilities provided by Stanbic Bank that will help it increase manufacturing capacity and introduce new products
Quality Chemical Industries Ltd: Notice of annual general meeting
The annual general meeting (AGM) of Quality Chemical Industries Limited (the Company) for the year ending 31 March 2025 will be held electronically on Thursday, 17 July 2025 at 11:00 am EAT
Pharmaceuticals sector
Quality Chemicals secures $36mn funding from Stanbic Bank to expand production
Quality Chemical Industries Limited, the pharmaceutical company, has secured a $36mn debt facility from Stanbic Bank Uganda for the construction of a second manufacturing facility
Quality Chemical Industries Ltd